A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
Inside the deadly disease confounding medicine, researchers piecing together clues and the breakthrough that meant survival ...
Liver fibrosis represents a serious worldwide health issue with a prevalence of around 5% in general populations.1 The most ...
BACKGROUND: Genetic variants in components or regulators of the RAS-MAPK signaling pathway are causative for severe and early-onset hypertrophic cardiomyopathy (HCM) in patients with Noonan syndrome ...